Home » Article
After a diagnosis of prostate cancer, people may be motivated to take an active role in their health and make lifestyle changes to enhance their recovery. Fortunately, there are a few simple dietary changes you can make, backed by science. In a recent webinar, PCF-funded investigator Dr. Stacey Kenfield discussed. Read More
When Brian Germain (currently 63) turned 60, he figured he would finally go see a doctor to get a physical. “Yeah, I had been training on the mats since I was almost 13. I had fought on USA Judo’s national team several times in my 20’s and early 30’s. Then. Read More
The Prostate Cancer Foundation (PCF) is sad to share news of the recent passing of a giant in the field of genitourinary (GU) medical oncology, Dr. Nicholas J. Vogelzang. Dr. Vogelzang (or Nick, as many of his colleagues knew him) dedicated his professional life to researching and treating rare forms. Read More
As we age, fatigue, nagging aches and pains, and chronic health problems can become barriers to regular exercise. But it’s just as important to maintain an exercise routine (or start a new one) at age 65 as it is at age 35. Whether you’re new to exercise or a regular. Read More
Hispanic Heritage Month runs from September 15 to October 15. Below, Dr. Scarlett Gomez, a professor of epidemiology and biostatistics at the University of California, San Francisco, and an expert on cancer disparities, describes how prostate cancer is affecting Hispanic/Latino men. Key Takeaways: Prostate cancer remains a significant burden for. Read More
Plant-based diets, Meatless Monday, “Veganuary”…..there’s a lot of talk these days about the potential health benefits, as well as environmental benefits, of eating less meat. For example, a study of more than 200,000 men in the U.K. showing that men who were vegetarian, and men who ate fish (but no. Read More
A whole new form of treatment for metastatic castrate-resistant prostate cancer (mCRPC) is here: PSMA-targeting therapy. The first PSMA-targeting therapy approved in the U.S. – with more being tested now in clinical trials – is LuPSMA (177Lu-PSMA-617; Pluvicto®), previously discussed here. We asked medical oncologist and PCF-funded scientist Michael J.. Read More
PSMA is a molecule that sits on the surface of prostate cancer cells, and we can look right at it. It can’t hide from us – even in bits of cancer no bigger than a grain of rice – because, thanks to research funded by PCF, newly-approved radioactive tracers that. Read More
Over the past 29 years, many generous supporters, large and small, have contributed to the Prostate Cancer Foundation’s efforts to fund life-saving prostate cancer research. One source of support has been steadily increasing over nearly a decade, becoming the largest single private fundraiser benefiting PCF: the Wild Dunes Men’s Golf. Read More
Men undergoing surgery for prostate cancer often fear its side effects, including losing the ability to have erections. PCF-funded investigator Dr. Ashutosh Tewari, chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital, and team have reviewed the latest research on strategies to improve erectile function that. Read More